In neonates, especially those in the neonatal intensive care unit (NICU), early identification of sepsis and other infections is crucial for timely intervention and treatment. Traditional markers like C-reactive protein (CRP) or white blood cell count (WBC) can be non-specific and sometimes delayed. Procalcitonin has emerged as a more specific and earlier marker for bacterial infections, making it particularly useful in the neonatal context.
